Skip to main content
. 2022 Dec 20;11(1):4. doi: 10.3390/vaccines11010004

Table 2.

Baseline characteristics of study sample (n = 272).

Variable Entire Sample (n = 272)
n %
Gender
Male 135 49.6
Female 137 50.4
Ethnicity
African 161 59.2
Indian 25 9.2
Mixed/Other 84 30.9
Non-responder 2 0.7
Marital status
Married 28 10.3
Single 179 65.8
Common law/Other 65 23.9
Education level
Primary school or below 41 15.1
Secondary school 172 63.2
University or above 58 21.3
Non-responder 1 0.4
Employment status
Employed 137 50.4
Unemployed 107 39.3
Other 28 10.3
Sexual orientation
Heterosexual 192 70.6
Non-heterosexual 68 25.0
Non-responder 12 4.4
Previous or current exposure to COVID-19 disease
No 249 91.5
Yes 19 7.0
Non-responder 4 1.5
Family/friends contracting COVID-19
No 202 74.3
Yes 70 25.7
Existing chronic diseases
No 195 71.7
Yes 73 26.8
Non-responder 4 1.5
Self-rated health status
Poor health 55 20.2
Good health 217 79.8
Confidence in the COVID-19 vaccine
Not confident 139 51.1
Confident 129 47.4
Non-responder 4 1.5
Viral suppression
Not suppressed 39 14.3
Suppressed 229 84.2
COVID-19 vaccination intention
Do not intend to get vaccinated 106 39.0
Intend to get vaccinated 163 59.9
Non-responder 3 1.1
Mean ± SD
Age (years) 41.7 ± 13.0
Length of time since HIV diagnosis and initiation on ART (years) 8.73 ± 6.02